Get the Stockscreener App
85.26
0.01%
0.01
After Hours:
85.26
Solventum Corp stock is traded at $85.26, with a volume of 929.66K.
It is up +0.01% in the last 24 hours and up +24.30% over the past month.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
See More
Previous Close:
$85.25
Open:
$85.16
24h Volume:
929.66K
Relative Volume:
0.86
Market Cap:
$14.79B
Revenue:
$8.31B
Net Income/Loss:
$379.00M
P/E Ratio:
39.47
EPS:
2.16
Net Cash Flow:
$385.00M
1W Performance:
-0.01%
1M Performance:
+24.30%
6M Performance:
+13.47%
1Y Performance:
+21.35%
1-Day Range:
$84.66
$85.64
1-Week Range:
$84.29
$88.20
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
85.26 | 14.79B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
568.65 | 201.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.76 | 55.25B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.99 | 39.31B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.51 | 36.70B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
281.77 | 20.45B | 2.96B | 487.70M | 344.00M | 6.6758 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
What is the fair value estimate for Solventum Corporation (KB7) stock in 2025Quarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Solventum Corporation (SOLV) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Solventum (NYSE:SOLV) Reaches New 12-Month HighWhat's Next? - MarketBeat
Solventum Corporation's (NYSE:SOLV) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - 富途牛牛
Why Solventum Corporation stock stays resilient2025 Price Action Summary & Step-by-Step Trade Execution Guides - Newser
What macro factors could drive Solventum Corporation (KB7) stock higherQuarterly Portfolio Review & Technical Analysis for Trade Confirmation - Newser
Can Solventum Corporation stock resist broad market declinesTrade Exit Summary & Weekly Breakout Stock Alerts - Newser
What Wall Street predicts for Solventum Corporation stock price2025 Volume Leaders & Expert Curated Trade Ideas - Newser
Solventum’s End-of-Year Rebound - Medical Device and Diagnostic industry
Transcript : Solventum Corporation Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 10 - MarketScreener
Solventum gets an analyst upgrade to ‘Buy’ on expected upside - MassDevice
Why Solventum Corporation (KB7) stock attracts HNW investorsJuly 2025 Market Mood & AI Powered Market Entry Strategies - Newser
Solventum stock rating upgraded to Buy at BTIG on improved execution By Investing.com - Investing.com Nigeria
Solventum stock rating upgraded to Buy at BTIG on improved execution - Investing.com India
BTIG Upgrades Solventum (SOLV) - Nasdaq
Can Solventum Corporation stock stage a strong rebound this quarter - Newser
BTIG Upgrades Solventum to Buy From Neutral, Price Target is $100 - MarketScreener
BTIG upgrades Solventum to Buy on better setup in 2026 - TipRanks
Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity - Investing.com
How big funds are accumulating Solventum Corporation (KB7) stockJuly 2025 Pullbacks & Weekly Top Gainers Alerts - Newser
Will Solventum Corporation stock beat international competition2025 Trading Recap & Growth Oriented Trade Recommendations - Newser
Why Solventum Corporation stock stays on top picksJuly 2025 EndofMonth & Weekly Momentum Stock Picks - Newser
Solventum Simplifies Dental Care with Advanced Fluoride Innovation - bangkokpost.com
A Look at Solventum’s Valuation Following Its $1 Billion Share Buyback Announcement - simplywall.st
Why retail investors pile into Solventum Corporation stock2025 Historical Comparison & Growth-Oriented Investment Plans - BỘ NỘI VỤ
The Beat: ShopFloor Coffee eyes Walmart; Apasa Foods strategy, Solventum deal - The Business Journals
Is Solventum’s (SOLV) Billion-Dollar Buyback a Signal of Strength or Strategic Caution? - simplywall.st
Solventum's second-quarter profit falls 70% on higher expenses - AOL.com
Solventum Corp (1SOLV.MI) Stock Major Holders - Yahoo! Finance Canada
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference - Eastern Progress
9-Day Rally Sends Solventum Stock Up 16% - Trefis
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference (2025-11-25) - Seeking Alpha
Solventum Corp stock hits 52-week high at 85.92 USD By Investing.com - Investing.com South Africa
Solventum Corp stock hits 52-week high at 85.92 USD - Investing.com
Model ML raises again, gene-editing gains backers and Solventum's wound care buy - Axios
Solventum to buy private wound care firm Acera for up to $850M - MSN
Solventum Stock Surges 13%, With A 8-Day Winning Spree - Trefis
Solventum to acquire Acera Surgical in $725 million deal - Indian Pharma Post
Solventum (SOLV): Assessing Valuation After $1 Billion Share Buyback Announcement - Yahoo Finance
Solventum Seeks to Chart Its Own Path, Improve Operations, and Raise Profitability - Morningstar
Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition - Yahoo Finance
Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock - Fierce Biotech
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Solventum: Setting Up For Growth And A Re-Rating (NYSE:SOLV) - Seeking Alpha
Solventum sets $1 billion share repurchase program - MSN
Quick ratio of Solventum Corporation – HAM:KB7 - TradingView
Solventum To Buy Acera Surgical In $850 Million Deal To Expand Advanced Wound Care Portfolio - Pulse 2.0
Solventum stock rating reiterated by UBS, Acera deal fills wound care gap - Investing.com South Africa
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Finviz
A Look at Solventum’s Valuation Following $1 Billion Share Buyback Authorization - simplywall.st
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Solventum Corp Stock (SOLV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| 3M CO | 10% Owner |
Aug 15 '25 |
Sale |
73.45 |
8,800,000 |
646,360,000 |
25,569,190 |
| COX CARRIE SMITH | Director |
May 13 '25 |
Option Exercise |
0.00 |
5,148 |
0 |
5,148 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
1.74%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):